A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg

Clinical trial NCT06965998 · RECRUITING

Trial details

NCT number: NCT06965998
Sponsor: Ottawa Hospital Research Institute
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

SVT Thrombosis Superficial Vein Thrombosis

Start date: 2025-08-06
Primary completion: 2026-08-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.